Articles | Volume 6, issue 4
https://doi.org/10.5194/jbji-6-107-2021
https://doi.org/10.5194/jbji-6-107-2021
Case report
 | 
22 Feb 2021
Case report |  | 22 Feb 2021

Mycobacterium bovis BCG osteoarticular infection complicating immune therapy for bladder cancer: a case report

Rebecca Stern, Clay Roscoe, and Elizabeth A. Misch

Cited articles

Hlavsa, M. C., Moonan, P. K., Cowan, L. S., Navin, T. R., Kammerer, J. S., Morlock, G. P., Crawford, J. T., and LoBue, P. A.: Human Tuberculosis due to Mycobacterium bovis in the United States, 1995–2005, Clin. Infect. Dis., 47, 168–175, https://doi.org/10.1086/589240, 2008. 
Hogan, J. I., Hurtado, R. M., and Nelson, S. B.: Mycobacterial Musculoskeletal Infections, Infect. Dis. Clin. North Am., 31, 369–382, https://doi.org/10.1016/j.idc.2017.01.007, 2017. 
Lamm, D. L.: Efficacy and safety of bacille Calmette-Guérin immunotherapy in superficial bladder cancer, Clin. Infect. Dis., 31, Suppl. 3, S86–90, https://doi.org/10.1086/314064, 2000. 
Liu, Y., Lu, J., Huang, Y., and Ma, L.: Clinical Spectrum of Complications Induced by Intravesical Immunotherapy of Bacillus Calmette-Guérin for Bladder Cancer, J. Oncol., 2019, 6230409, https://doi.org/10.1155/2019/6230409, 2019. 
Nguyen, M. H., Giordani, M. M., and Thompson III, G. R.: The double-edged sword – prosthetic joint infection following BCG treatment for bladder cancer: a case report, BMC Infect. Dis., 19, 331, https://doi.org/10.1186/s12879-019-3951-1, 2019. 
Download
Short summary
This case highlights clinical and laboratory diagnostic challenges encountered with mycobacterial osteoarticular infections. Specifically, we focus on a rare complication of prosthetic joint infection following BCG therapy for non-muscle-invasive bladder cancer. We emphasize awareness of host risk factors to encourage consideration of mycobacteria in the relevant context.